financetom
Business
financetom
/
Business
/
AST SpaceMobile Stock Is Sliding Tuesday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AST SpaceMobile Stock Is Sliding Tuesday: What's Going On?
Oct 7, 2025 6:39 AM

AST SpaceMobile Inc ( ASTS ) shares are trading lower Tuesday after the company filed for an $800 million offering.

What Happened: AST SpaceMobile ( ASTS ) entered into an Equity Distribution Agreement to sell up to $800 million of the company’s common stock in an at-the-market offering program with up to a three-year term.

Under the agreement, AST SpaceMobile ( ASTS ) may sell shares from time to time through sales agents. The agents will be entitled to a commission rate of up to 3% of the gross sales price per share sold.

AST SpaceMobile ( ASTS ) had over $1.5 billion in cash, cash equivalents and restricted cash as of June 30.

How To Buy ASTS Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in AST SpaceMobile's ( ASTS ) case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

ASTS Price Action: AST SpaceMobile ( ASTS ) shares were down 6.28% at $68.32 at the time of publication on Tuesday, according to Benzinga Pro.

AST SpaceMobile ( ASTS ) stock is hovering near its 52-week high of $74.77. Despite the dip on Tuesday, it's still trading 39.7% above its 50-day moving average. The stock has an RSI of 79.5, suggesting it’s pretty overbought right now.

Read Next:

Chamath Says Earth Can’t Power AI — Bezos, Arista, Rocket Lab Have A Space Solution

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MercadoLibre to invest $11 billion in Brazil this year
MercadoLibre to invest $11 billion in Brazil this year
Mar 24, 2026
SAO PAULO, March 24 (Reuters) - E-commerce firm MercadoLibre ( MELI ) will invest 57 billion reais ($10.9 billion) in its main market Brazil this year, up 50% from 2025, it said on Tuesday. MercadoLibre ( MELI ) said the amount, which includes some operating costs and expenses, will be mainly used on logistics expansion, as well as to strengthen...
Velo3D Delivers Better-Than-Expected Q4 Results, Enters 2026 With 'Tremendous' Momentum
Velo3D Delivers Better-Than-Expected Q4 Results, Enters 2026 With 'Tremendous' Momentum
Mar 24, 2026
Velo3D Inc ( VELO ) reported fourth-quarter financial results after the market close on Tuesday. Here’s a look at the key details from the print. Velo3D ( VELO ) stock is charging ahead with explosive momentum. Why are VELO shares rallying? Velo3D Beats Estimates In Q4 Velo3D ( VELO ) reported fourth-quarter revenue of $9.44 million, beating analyst estimates of $8.68 million, according...
Cardlytics Closes Sale of Bridg Assets to PAR Technology
Cardlytics Closes Sale of Bridg Assets to PAR Technology
Mar 24, 2026
04:37 PM EDT, 03/24/2026 (MT Newswires) -- Cardlytics ( CDLX ) said Tuesday it has closed the sale of its Bridg assets to PAR Technology ( PAR ) for about 1.8 million PAR shares. We expect to monetize this position strategically based on market conditions, which will meaningfully strengthen our balance sheet, said Chief Financial Officer David Evans. We anticipate...
United Therapeutics Insider Sold Shares Worth $5,006,558, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $5,006,558, According to a Recent SEC Filing
Mar 24, 2026
04:37 PM EDT, 03/24/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on March 23, 2026, sold 9,500 shares in United Therapeutics ( UTHR ) for $5,006,558. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,872 common shares of the company, with 40,513 shares held directly and 639,359 controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved